SW

Santosh Waman Mutkule

Active Director Director DIN 02801231
DIN 02801231 First appointment Nov 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Nov 2009
Shareholding value •••• Premium profile

About Santosh Waman Mutkule

Data last updated:

Santosh Waman Mutkule is a Director at Sanpras Healthcare Private Limited (since 2009), Director at Khyati Healthcare Private Limited (since 2020) and Director at Godavari Agrocorn Farmers Producer Company Limited (since 2022). The companies operate in Pharma, Agriculture and Paper. The 3 current companies with reported revenue have a combined latest revenue of ₹98.21 Cr; the largest is Sanpras Healthcare Private Limited at ₹53.35 Cr (FY 2025). Earlier, Santosh Waman Mutkule was a Director at Sagl Life Sciences Private Limited (2023–2025).

DIN 02801231
Primary Designation Director
Industry Pharma
First Appointment 09 Nov 2009
Oldest Company Age 17 yrs
Largest company Sanpras Healthcare Private Limited · ₹53.35 Cr (FY 2025)
Combined revenue ₹98.21 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sanpras Healthcare Private Limited U85100MH2009PTC196966
Director09 Nov 20092009₹53.35 Cr (FY 2025)Active
Khyati Healthcare Private Limited U24290MH2020PTC347944
Director16 Nov 20202020₹44.44 Cr (FY 2025)Active
Director20 Jul 20222022₹40.9 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sagl Life Sciences Private Limited U21001MH2023PTC405559
Director28 Jun 20232023Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Godavari Agrocorn Farmers Producer Company Limited
Khyati Healthcare Private Limited
Sanpras Healthcare Private Limited
Sagl Life Sciences Private Limited
Premium access

Shareholding and investment profile for Santosh Waman Mutkule

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santosh Waman Mutkule

Santosh Waman Mutkule currently holds 3 directorships: Sanpras Healthcare Private Limited (Director, since 09 Nov 2009, revenue ₹53.35 Cr (FY 2025)); Khyati Healthcare Private Limited (Director, since 16 Nov 2020, revenue ₹44.44 Cr (FY 2025)); Godavari Agrocorn Farmers Producer Company Limited (Director, since 20 Jul 2022, revenue ₹40.9 Lakh (FY 2025)).

Santosh Waman Mutkule was first appointed on 09 Nov 2009 as Director at Sanpras Healthcare Private Limited. The most recent appointment on record is 28 Jun 2023 at Sagl Life Sciences Private Limited.

The 3 current companies of Santosh Waman Mutkule that report revenue have a combined latest revenue of ₹98.21 Cr: Sanpras Healthcare Private Limited ₹53.35 Cr (FY 2025); Khyati Healthcare Private Limited ₹44.44 Cr (FY 2025); Godavari Agrocorn Farmers Producer Company Limited ₹40.9 Lakh (FY 2025).

Santosh Waman Mutkule held 1 earlier board appointment: Sagl Life Sciences Private Limited (Director, 28 Jun 2023 to 21 Feb 2025).

The current boards of Santosh Waman Mutkule's companies include Ramesh Narandas Rughani (Sanpras Healthcare Private Limited), Sunanda Vaman Mutkule (Sanpras Healthcare Private Limited), Khyati Ramesh Rughani (Khyati Healthcare Private Limited), Kshitij Dinesh Kamat (Khyati Healthcare Private Limited), Dattatrey Eknath Pagar (Godavari Agrocorn Farmers Producer Company Limited), Rajaram Ganpat Pawar (Godavari Agrocorn Farmers Producer Company Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available